They concluded that OCT2 and BOB1 may be the most useful for determining B cell lineage in CD20 negative DLBCL cases, such as plasmablastic lymphoma and primary effusion lymphoma. This evidence concerns the gene POU2AF1 and diffuse large B-cell lymphoma.